Immunomodulation of autoimmune and systemic inflammatory diseases with intravenous immunoglobulin.
Service d'Immunologie, Hopital Broussais, Paris, France.
L
L
Mouthon
C
C
Piketty
M D
MD
Kazatchkine
D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007141:Immunoglobulin Fc Fragments / Q000276:immunology; D007135:Immunoglobulin Variable Region / Q000276:immunology; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D007249:Inflammation / Q000276:immunology / Q000628:therapy*; D051379:Mice; D016688:Mice, Inbred NOD; D008814:Mice, Inbred NZB; D016032:Randomized Controlled Trials as Topic; D012449:Safety
D007141:Immunoglobulin Fc Fragments; D007135:Immunoglobulin Variable Region; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors